Please join members of King & Spalding’s FDA and Life Sciences and Product Liability and Mass Torts teams to discuss the latest on AI in the life sciences and the related regulatory and legal risks.

This roundtable will discuss recent developments in the regulation of AI and machine learning specific to the life cycle of pharmaceutical products and medical devices, share views on the future landscape of AI regulation and litigation, including what companies should keep in mind with deploying AI today and facing discovery in the future, and discuss strategies pharmaceutical and medical device companies can deploy now to mitigate risks.